100 related articles for article (PubMed ID: 2554357)
1. Reduction of immunoreactive ACTH in plasma following intravenous injection of delta sleep-inducing peptide in man.
Bjartell A; Ekman R; Bergquist S; Widerlöv E
Psychoneuroendocrinology; 1989; 14(5):347-55. PubMed ID: 2554357
[TBL] [Abstract][Full Text] [Related]
2. Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion.
Späth-Schwalbe E; Schäfer A; Uthgenannt D; Born J; Fehm HL
Psychoneuroendocrinology; 1995; 20(3):231-7. PubMed ID: 7777652
[TBL] [Abstract][Full Text] [Related]
3. Different effects of delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men.
Chiodera P; Volpi R; Capretti L; Giacalone G; Caffarri G; Davoli C; Nigro E; Coiro V
Horm Res; 1994; 42(6):267-72. PubMed ID: 7698722
[TBL] [Abstract][Full Text] [Related]
4. Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Comparison with CRH-induced corticotropin and cortisol secretion.
Lesch KP; Widerlöv E; Ekman R; Laux G; Schulte HM; Pfüller H; Beckmann H
Biol Psychiatry; 1988 Jun; 24(2):162-72. PubMed ID: 2839244
[TBL] [Abstract][Full Text] [Related]
5. Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.
Friedman TC; Garcia-Borreguero D; Hardwick D; Akuete CN; Stambuk MK; Dorn LD; Starkman MN; Loh YP; Chrousos GP
J Clin Endocrinol Metab; 1994 May; 78(5):1085-9. PubMed ID: 8175965
[TBL] [Abstract][Full Text] [Related]
6. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
Westrin A; Ekman R; Träskman-Bendz L
Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
[TBL] [Abstract][Full Text] [Related]
7. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.
Friedman TC; García-Borreguero D; Hardwick D; Akuete CN; Doppman JL; Dorn LD; Barker CN; Yanovski JA; Chrousos GP
Neuroendocrinology; 1994 Dec; 60(6):626-34. PubMed ID: 7700506
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive delta sleep-inducing peptide in pituitary adrenocorticotropin/alpha-melanotropin cells and adrenal medullary cells of the pig.
Ekman R; Bjartell A; Ekblad E; Sundler F
Neuroendocrinology; 1987 Apr; 45(4):298-304. PubMed ID: 3033539
[TBL] [Abstract][Full Text] [Related]
9. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
Crofford LJ; Kalogeras KT; Mastorakos G; Magiakou MA; Wells J; Kanik KS; Gold PW; Chrousos GP; Wilder RL
J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive delta sleep-inducing peptide secretion from mouse dissociated, anterior pituitary cells: regulation by corticotropin-releasing factor and arginine vasopressin.
Bjartell A; Castro MG; Ekman R; Sundler F; Widerlöv E; Loh YP
Neuroendocrinology; 1989 Nov; 50(5):564-9. PubMed ID: 2558325
[TBL] [Abstract][Full Text] [Related]
13. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
Life Sci; 1989; 44(15):1043-51. PubMed ID: 2538698
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.
Tuchelt H; Dekker K; Bähr V; Oelkers W
Clin Endocrinol (Oxf); 2000 Sep; 53(3):301-7. PubMed ID: 10971446
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
16. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
Psychoneuroendocrinology; 2010 Nov; 35(10):1438-45. PubMed ID: 20554120
[TBL] [Abstract][Full Text] [Related]
17. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.
Kling MA; Demitrack MA; Whitfield HJ; Kalogeras KT; Listwak SJ; DeBellis MD; Chrousos GP; Gold PW; Brandt HA
Neuroendocrinology; 1993 Jun; 57(6):1082-91. PubMed ID: 8232766
[TBL] [Abstract][Full Text] [Related]
18. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N
Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
[TBL] [Abstract][Full Text] [Related]
19. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
